The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Bone Morphogenetic Protein-2 Stimulates Angiogenesis in Developing Tumors
Open accessAbstract
Bone Morphogenetic Protein-2 (BMP-2) is highly overexpressed in the majority of patient-derived lung carcinomas. However, a mechanism revealing its role in cancer has not been established. Here we report that BMP-2 enhances the neovascularization of developing tumors. Recombinant BMP-2 stimulated blood vessel formation in tumors formed from A549 cells injected s.c. into thymic nude mice. Recombinant BMP-2 also enhanced angiogenesis in Matrigel plugs containing A549 cells in nude mice. The BMP-2 antagonist noggin abrogated BMP-2-induced angiogenic response. Furthermore, antisense transfection of BMP-2 cDNA resulted in a decrease in blood vessel formation in the Matrigel assays. BMP-2 induced tube formation in both human aortic endothelial cells (HAEC) and umbilical vein endothelial cells. BMP-2 also stimulated proliferation of HAEC. The ability of BMP-2 to activate endothelial cells was further demonstrated by its ability to phosphorylate Smad 1/5/8 and ERK-1/2 and to increase expression of Id1. This study reveals that BMP-2 enhanced the angiogenic response in developing tumors. Furthermore, these data suggest that BMP-2 stimulation of angiogenesis may involve the activation of endothelial cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Novel Regulators of Bone Formation: Molecular Clones and Activities
Wozney, J. M., Rosen, V., Celeste, A. J., Mitsock, L. M., Whitters, M. J., Kriz, R. W., Hewick, R. M., & Wang, E. A. (1988) · Science · doi:10.1126/science.3201241 · Cited by 3,903
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860
Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse.
Winnier, G., Blessing, M., Labosky, P. A., & Hogan, B. L. (1995) · Genes & Development · doi:10.1101/gad.9.17.2105 · Cited by 1,788
The Spemann Organizer Signal noggin Binds and Inactivates Bone Morphogenetic Protein 4
Zimmerman, L. B., De Jesús-Escobar, J. M., & Harland, R. M. (1996) · Cell · doi:10.1016/s0092-8674(00)80133-6 · Cited by 1,633
Bmp4 is required for the generation of primordial germ cells in the mouse embryo
Lawson, K. A., Dunn, N. R., Roelen, B. A. J., Zeinstra, L. M., Davis, A. M., Wright, C. V. E., Korving, J. P. W. F. M., & Hogan, B. L. M. (1999) · Genes & Development · doi:10.1101/gad.13.4.424 · Cited by 1,310
Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts
Lyden, D., Young, A. Z., Zagzag, D., Yan, W., Gerald, W., O'Reilly, R., Bader, B. L., Hynes, R. O., Zhuang, Y., Manova, K., et al. (1999) · Nature · doi:10.1038/44334 · Cited by 922
Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1
Kretzschmar, M., Doody, J., & Massagu, J. (1997) · Nature · doi:10.1038/39348 · Cited by 877
Celeste, A. J., Iannazzi, J. A., Taylor, R. C., Hewick, R. M., Rosen, V, Wang, E. A., & Wozney, J. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.24.9843 · Cited by 826
Noggin, Cartilage Morphogenesis, and Joint Formation in the Mammalian Skeleton
Brunet, L. J., McMahon, J. A., McMahon, A. P., & Harland, R. M. (1998) · Science · doi:10.1126/science.280.5368.1455 · Cited by 825
Mishina, Y., Suzuki, A., Ueno, N., & Behringer, R. R. (1995) · Genes & Development · doi:10.1101/gad.9.24.3027 · Cited by 776
Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4.
ten Dijke, P., Yamashita, H., Sampath, T. K., Reddi, A. H., Estevez, M., Riddle, D. L., Ichijo, H., Heldin, C. H., & Miyazono, K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32506-1 · Cited by 730
Deckers, M. M. L. (2002) · Endocrinology · doi:10.1210/en.143.4.1545 · Cited by 650
Kishimoto, Y., Lee, K.-H., Zon, L., Hammerschmidt, M., & Schulte-Merker, S. (1997) · Development · doi:10.1242/dev.124.22.4457 · Cited by 519
Vermeulen, P. B., Gasparini, G., Fox, S. B., Colpaert, C., Marson, L. P., Gion, M., Beliën, J. A. M., de Waal, R. M. W., Van Marck, E., Magnani, E., et al. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00094-1 · Cited by 488
Transformation of Tooth Type Induced by Inhibition of BMP Signaling
Tucker, A. S., Matthews, K. L., & Sharpe, P. T. (1998) · Science · doi:10.1126/science.282.5391.1136 · Cited by 447
Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects
Chang, H., Huylebroeck, D., Verschueren, K., Guo, Q., Matzuk, M. M., & Zwijsen, A. (1999) · Development · doi:10.1242/dev.126.8.1631 · Cited by 435
Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5
Yang, X., Castilla, L. H., Xu, X., Li, C., Gotay, J., Weinstein, M., Liu, P. P., & Deng, C.-X. (1999) · Development · doi:10.1242/dev.126.8.1571 · Cited by 388
Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice
Goumans, M. J., & Mummery, C. (2000) · The International Journal of Developmental Biology · doi:10.1387/ijdb.10853822 · Cited by 376
ten Dijke, P., Ichijo, H., Franzèn, P., Schulz, P. J., Saras, J., Toyoshima, H., Heldin, C., & Miyazono, K. (1993) · PubMed · Cited by 351
Abe, E., Yamamoto, M., Taguchi, Y., Lecka-Czernik, B., O'Brien, C. A., Economides, A. N., Stahl, N., Jilka, R. L., & Manolagas, S. C. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.4.663 · Cited by 319
Valdimarsdottir, G., Goumans, M.-J., Rosendahl, A., Brugman, M., Itoh, S., Lebrin, F., Sideras, P., & ten Dijke, P. (2002) · Circulation · doi:10.1161/01.cir.0000033830.36431.46 · Cited by 311
Wu, L.-W., Mayo, L. D., Dunbar, J. D., Kessler, K. M., Baerwald, M. R., Jaffe, E. A., Wang, D., Warren, R. S., & Donner, D. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.5096 · Cited by 286
Id proteins in cell cycle control and cellular senescence
Zebedee, Z., & Hara, E. (2001) · Oncogene · doi:10.1038/sj.onc.1205092 · Cited by 282
Cunningham, N. S., Paralkar, V, & Reddi, A. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.11740 · Cited by 241
Moser, M., Binder, O., Wu, Y., Aitsebaomo, J., Ren, R., Bode, C., Bautch, V. L., Conlon, F. L., & Patterson, C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.16.5664-5679.2003 · Cited by 231
BMP-4 is proteolytically activated by furin and/or PC6 during vertebrate embryonic development
Cui, Y. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4735 · Cited by 230
When cell biology meets development: endocytic regulation of signaling pathways
Seto, E. S., Bellen, H. J., & Lloyd, T. E. (2002) · Genes & Development · doi:10.1101/gad.989602 · Cited by 227
The Id proteins and angiogenesis
Benezra, R., Rafii, S., & Lyden, D. (2001) · Oncogene · doi:10.1038/sj.onc.1205160 · Cited by 222 · cited 1×
“Studies have demonstrated that Id has an important role in mediating an angiogenic response during embryonic development and on postnatal endothelial cells (33).”
BackgroundTargeted Mutagenesis of Smad1 Reveals an Essential Role in Chorioallantoic Fusion
Lechleider, R. J., Ryan, J. L., Garrett, L., Eng, C., Deng, C.-X., Wynshaw-Boris, A., & Roberts, A. B. (2001) · Developmental Biology · doi:10.1006/dbio.2001.0469 · Cited by 185
Langenfeld, E. M. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg100 · Cited by 181
Self-citationKleeff, J., Maruyama, H., Ishiwata, T., Sawhney, H., Friess, H., Büchler, M. W., & Korc, M. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70024-7 · Cited by 177
Suzawa, M., Takeuchi, Y., Fukumoto, S., Kato, S., Ueno, N., Miyazono, K., Matsumoto, T., & Fujita, T. (1999) · Endocrinology · doi:10.1210/endo.140.5.6704 · Cited by 164
Growth regulation of human prostate cancer cells by bone morphogenetic protein-2.
Ide, H., Yoshida, T., Matsumoto, N., Aoki, K., Osada, Y., Sügimura, T., & Terada, M. (1997) · PubMed · Cited by 152
Sakou, T., Onishi, T., Yamamoto, T., Nagamine, T., Sampath, T. K., & ten Dijke, P. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.7.1145 · Cited by 150
Lou, J., Tu, Y., Li, S., & Manske, P. R. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2210 · Cited by 142
Tanaka, K., Abé, M., & Sato, Y. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00796.x · Cited by 126
BMP-2 Gene Expression and Effects on Human Vascular Smooth Muscle Cells
Willette, R. N., Gu, J. L., Lysko, P. G., Anderson, K. M., Minehart, H., & Yue, T.-L. (1999) · Journal of Vascular Research · doi:10.1159/000025634 · Cited by 123
Xiao, Z., Watson, N., Rodríguez, C., & Lodish, H. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103117200 · Cited by 116
Non-Small Cell Lung Cancer Cells Induce Monocytes to Increase Expression of Angiogenic Activity
White, E. S., Strom, S. R. B., Wys, N. L., & Arenberg, D. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7549 · Cited by 107
Yeh, L. C., & Lee, J. C. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00076-3 · Cited by 102
The Helix–Loop–Helix Protein Id-1 Delays Onset of Replicative Senescence in Human Endothelial Cells
Tang, J., Gordon, G. M., Nickoloff, B. J., & Foreman, K. E. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000022223.65962.3a · Cited by 95
Ghosh‐Choudhury, N., Woodruff, K. A., Qi, W., Celeste, A. J., Abboud, S. L., & Choudhury, G. G. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2844 · Cited by 87
Angiogenin Activates Erk1/2 in Human Umbilical Vein Endothelial Cells
Liu, S., Yu, D., Xu, Z., Riordan, J. F., & Hu, G. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5568 · Cited by 79
Overexpression of BMP-2/4, -5 and BMPR-IA associated with malignancy of oral epithelium
Jin, Y. (2001) · Oral Oncology · doi:10.1016/s1368-8375(00)00087-7 · Cited by 69
Tada, A., Nishihara, T., & Kato, H. (1998) · Oncology Reports · doi:10.3892/or.5.5.1137 · Cited by 18
Cited by
The role of microenvironment in tumor angiogenesis
Jiang, X., Wang, J., Deng, X., Xiong, F., Zhang, S., Gong, Z., Li, X., Cao, K., Deng, H., He, Y., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01709-5 · Cited by 761
Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling
Bluemn, E. G., Coleman, I. M., Lucas, J. M., Coleman, R. T., Hernandez-Lopez, S., Tharakan, R., Bianchi-Frias, D., Dumpit, R. F., Kaipainen, A., Corella, A. N., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.09.003 · Cited by 744
“ID1 expression is induced by exogenous FGF and bone morphogenetic protein via MAPK pathway activation (Langenfeld and Langenfeld, 2004; Passiatore et al., 2011), prevents differentiation by binding cell lineage-specific transcription factors (Perk et al.”
BackgroundTGF-β signaling in vascular biology and dysfunction
Goumans, M.-J., Liu, Z., & ten Dijke, P. (2009) · Cell Research · doi:10.1038/cr.2008.326 · Cited by 601
Scharpfenecker, M., van Dinther, M., Liu, Z., van Bezooijen, R. L., Zhao, Q., Pukac, L., Löwik, C. W. G. M., & ten Dijke, P. (2007) · Journal of Cell Science · doi:10.1242/jcs.002949 · Cited by 531
Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer
Pardali, K., & Moustakas, A. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.06.004 · Cited by 526
Metadata
- Authors
- Langenfeld, E. M., & Langenfeld, J.
- Venue
- Molecular Cancer Research
- Published
- 2004-03-01
- Volume
- 2
- Issue
- 3
- Pages
- 141-149
- ISSN
- 1541-7786 (ISSN-L)
- 1557-3125
- OpenAlex
- W2332237703
- Cited by
- 284
- References
- 45
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.